Methyltris(tert-butylperoxy)silane | CAS:10196-45-9

We serve Methyltris(tert-butylperoxy)silane CAS:10196-45-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyltris(tert-butylperoxy)silane

Chemical Name:Methyltris(tert-butylperoxy)silane
CAS.NO:10196-45-9
Synonyms:tris-tert-butylperoxy-methyl-silane; Tris-tert-butylperoxy-methyl-silan; tris(tert-butyldioxy)methylsilane; methyltri(tert-butylperoxysilane); 
Silane,tris[(1,1-dimethylethyl)dioxy]methyl;
Molecular Formula:C13H30O6Si
Molecular Weight:310.45900
 
Specification:
Appearance:Colorless clear liquid
Purity:40% in Toluene solution
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is a developmental product.



Contact us for information like Methyltris(tert-butylperoxy)silane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Silane,tris[(1,1-dimethylethyl)dioxy]methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyltris(tert-butylperoxy)silane Use and application,Silane,tris[(1,1-dimethylethyl)dioxy]methyl technical grade,usp/ep/jp grade.


Related News: The UK Foreign Office advised Britons against all but essential travel to mainland China, and airlines around the world suspended flights or offered full refunds or destination and date changes.2-chloro-6-methoxy-1,3-benzothiazole manufacturer Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoic acid supplier An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.9-(4-Bromophenyl)-10-phenylanthracene vendor Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.